Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Saintek Media Bootcamp Dorong Jurnalis Hadirkan Sains yang Dekat dengan Publik

Sains tidak akan bermakna tanpa jembatan komunikasi yang kuat antara peneliti dan masyarakat. Karena itu, jurnalis berperan penting dalam memastikan pengetahuan ilmiah tersampaikan secara jelas, relev...

Bantu atasi krisis kesehatan dan lingkungan, biologi sintetis perlu regulasi serius

● Biologi sintetis dapat menciptakan solusi untuk mengatasi krisis kesehatan hingga lingkungan.● Teknologi ini rentan dimonopoli dan disalahgunakan sehingga berisiko menimbulkan dampak eko...

Ruang sipil makin sempit, kaum muda makin takut berekspresi

MikailArvin/ShutterstockRuang sipil kini menjadi topik yang semakin penting dibicarakan. Di tengah dinamika politik dan derasnya arus informasi digital, muncul pertanyaan besar: seberapa bebas kaum mu...